Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0134076 | 0.303295 | 1 |
Trypanosoma brucei | thioredoxin | 0.00329228 | 0 | 0.5 |
Schistosoma mansoni | tyrosinase precursor | 0.0366436 | 1 | 1 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.00329228 | 0 | 0.5 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0134076 | 0.303295 | 1 |
Plasmodium vivax | thioredoxin 1, putative | 0.00329228 | 0 | 0.5 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0134076 | 0.303295 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.00474096 | 0.0434369 | 0.143216 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.00474096 | 0.0434369 | 0.143216 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Brugia malayi | geranylgeranyl pyrophosphate synthetase | 0.0134076 | 0.303295 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00329228 | 0 | 0.5 |
Chlamydia trachomatis | thioredoxin | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Mycobacterium tuberculosis | Thioredoxin TrxC (TRX) (MPT46) | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.00329228 | 0 | 0.5 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0134076 | 0.303295 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.00474096 | 0.0434369 | 0.143216 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.00329228 | 0 | 0.5 |
Onchocerca volvulus | 0.00474096 | 0.0434369 | 0.5 | |
Mycobacterium ulcerans | thioredoxin TrxB1 | 0.00329228 | 0 | 0.5 |
Entamoeba histolytica | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Leishmania major | polyprenyl synthase, putative | 0.0134076 | 0.303295 | 1 |
Onchocerca volvulus | 0.00474096 | 0.0434369 | 0.5 | |
Toxoplasma gondii | thioredoxin-like protein TLP1 | 0.00329228 | 0 | 0.5 |
Onchocerca volvulus | 0.00474096 | 0.0434369 | 0.5 | |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.00474096 | 0.0434369 | 0.143216 |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0134076 | 0.303295 | 1 |
Toxoplasma gondii | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.00329228 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | thioredoxin | 0.00329228 | 0 | 0.5 |
Entamoeba histolytica | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0134076 | 0.303295 | 0.303295 |
Loa Loa (eye worm) | hypothetical protein | 0.00474096 | 0.0434369 | 0.143216 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Mycobacterium ulcerans | thioredoxin TrxC | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Brugia malayi | Hypothetical tyrosinase-like protein C02C2.1 in chromosome III | 0.00474096 | 0.0434369 | 0.143216 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0134076 | 0.303295 | 1 |
Entamoeba histolytica | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.00329228 | 0 | 0.5 |
Brugia malayi | Hypothetical tyrosinase-like protein F21C3.2 in chromosome I | 0.00474096 | 0.0434369 | 0.143216 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.00329228 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable thioredoxin TrxB1 | 0.00329228 | 0 | 0.5 |
Schistosoma mansoni | tyrosinase precursor | 0.0366436 | 1 | 1 |
Mycobacterium ulcerans | thioredoxin TrxB1 | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Plasmodium falciparum | thioredoxin 1 | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Brugia malayi | ShTK domain containing protein | 0.00474096 | 0.0434369 | 0.143216 |
Onchocerca volvulus | 0.00474096 | 0.0434369 | 0.5 | |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | thioredoxin, putative | 0.00329228 | 0 | 0.5 |
Loa Loa (eye worm) | tyrosinase 1 | 0.00474096 | 0.0434369 | 0.143216 |
Brugia malayi | Common central domain of tyrosinase family protein | 0.00474096 | 0.0434369 | 0.143216 |
Loa Loa (eye worm) | ShTK domain-containing protein | 0.00474096 | 0.0434369 | 0.143216 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00329228 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00329228 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.9 nM | The compound was tested in vitro for the antimalarial activity against chloroquine-sensitive NF54 strain of Plasmodium falciparum | ChEMBL. | 10543871 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 10543871 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.